Lymphoma
Phase III
Accepting Patients
nct/study# NCT02972840 / ACE-LY-308
A Phase 3, Randomized, Double Blind, Placebo Controlled, Multicenter Study Of Bendamustine And Rituximab (BR) Alone Versus In Combination With Acalabrutinib (ACP 196) In Subjects With Previously Untreated Mantle Cell Lymphoma
Learn More
Lymphoma
Phase I/II
Accepting Patients
nct/study# NCT03218683 / D6910C00001
A Phase 1/1b/2a, 3-Part, Open-Label, Multicentre Study To Assess The Safety, Tolerability, Pharmacokinetics And Preliminary Antitumor Activity Of Ascending Doses Of AZD5991 In Subjects With Relapsed Or Refractory Haematologic Malignancies
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NCT03816683 / D8220R00004
Astrazeneca/ Treatment Patterns, Outcomes, And Patient-Reported Health-Related Quality Of Life: A Prospective Disease Registry Of Patients With Mantle Cell Lymphoma Treated With Novel Agents
Learn More
Lymphoma
Phase I
Accepting Patients
nct/study# NCT02500407 / GO29781
An Open-Label, Multicenter, Phase I Trial Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of BTCT4465A In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin?S Lymphoma And Chronic Lymphocytic Leukemia
Learn More
Lymphoma
Phase II
Accepting Patients
nct/study# NCT04002401 / KT-US-471-0114
A Phase 2 Open-Label, Multicenter Study Evaluating The Safety And Efficacy Of Axicabtagene Ciloleucel In Combination With Either Rituximab Or Lenalidomide In Subjects With Refractory Large B-Cell Lymphoma (ZUMA-14)
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / CORE-CLL-2018-0338
Chronic Lymphocytic Leukemia (Cll) Collaborative Study Of Real-World Evidence (Core)
Learn More
